U.S. Markets

Pfizer (PFE) and Blackstone (BX) Life Sciences have entered into a strategic financing partnership, under which Blackstone will commit up to USD 1.50bln to support Pfizer’s berobenatide obesity programme through 2028, with Pfizer maintaining full operatio

ORIGINAL · NewsquawkPfizer (PFE) and Blackstone (BX) Life Sciences have entered into a strategic financing partnership, under which Blackstone will commit up to USD 1.50bln to support Pfizer’s berobenatide obesity programme through 2028, with Pfizer maintaining full operatio
StockNow breaking-news AI analysis

Pfizer and Blackstone announced financing of up to USD 1.50bln for berobenatide through 2028, aligning with Pfizer’s previously reported target for a weekly version that year.

2 stocks

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more